Key result
Neomycin fixation plus ethanol pretreatment inhibits calcification and preserves glycosaminoglycans versus glutaraldehyde in rat implants.
Why the study?
Does neomycin fixation followed by ethanol pretreatment prevent calcification and preserve glycosaminoglycans in bioprosthetic heart valves compared to glutaraldehyde fixation?
Does neomycin fixation followed by ethanol pretreatment prevent calcification and preserve glycosaminoglycans in bioprosthetic heart valves compared to glutaraldehyde fixation?
Neomycin fixation followed by ethanol pretreatment of bioprosthetic heart valves preserves glycosaminoglycans and inhibits calcification in a rat model, potentially increasing valve durability.
Answers are grounded in this paper and cite their sources.
Should not yet change bioprosthetic valve fixation; hypothesis-generating for reduced calcification in clinical implants.
Glutaraldehyde crosslinked bioprosthetic heart valves (BHVs) have two modalities of failure: degeneration (cuspal tear due to matrix failure) and calcification. They can occur independently as well as one can lead to the other causing co-existence. Calcific failure has been extensively studied before and several anti-calcification treatments have been developed; however, little research is directed to understand mechanisms of valvular degeneration. One of the shortcomings of glutaraldehyde fixation is its inability to stabilize all extracellular matrix components in the tissue. Previous studies from our lab have demonstrated that neomycin could be used as a fixative to stabilize glycosaminoglycans (GAGs) present in the valve to improve matrix properties. But neomycin fixation did not prevent cuspal calcification. In the present study, we wanted to enhance the anti-calcification potential of neomycin fixed valves by pre-treating with ethanol or removing the free aldehydes by sodium borohydride treatment. Ethanol treatment has been previously used and found to have excellent anti-calcification properties for valve cusps. Results demonstrated in this study suggest that neomycin followed by ethanol treatment effectively preserves GAGs both in vitro as well as in vivo after subdermal implantation in rats. In vivo calcification was inhibited in neomycin fixed cusps pretreated with ethanol compared to glutaraldehyde (GLUT) control. Sodium borohydride treatment by itself did not inhibit calcification nor stabilized GAGs against enzymatic degradation. Neomycin fixation followed by ethanol treatment of BHVs could prevent both modalities of failure, thereby increasing the effective durability and lifetime of these bioprostheses several fold.
No takes yet. Share an insight, caveat, or question.
Raghavan et al. (2009) studied Bioprosthetic heart valve calcification and degeneration. Neomycin fixation followed by ethanol pretreatment vs. Glutaraldehyde (GLUT) control was evaluated on Calcification and glycosaminoglycan (GAG) stabilization. Neomycin fixation followed by ethanol pretreatment effectively preserved glycosaminoglycans and inhibited in vivo calcification in rat subdermal implants compared to glutaraldehyde control.
Synapse has enriched 10 related papers. Consider them for comparative context: